Similarly, the majority of NSGCTs (24 out of 38) found negative for CD44 staining in tumor cells (≤10% tumor cell positivity), whereas 14 out of 38 NSGCTs were positive for CD44 expression (>10% tumor cell positivity) (Table 2). This evidence concerns the gene CD44 and neoplasm.